BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2008
View Archived Issues
Vertex updates progress of key pipeline candidates
Read More
GSK-690693 safe, inhibits AKT in a first-in-human study
Read More
ANG-1005 allows transport of paclitaxel to the brain
Read More
Thapsigargin analogue developed as a treatment for cancer
Read More
PCI-27483 active against lung and pancreatic cancer in vivo
Read More
New ROCK inhibitor developed at Inspire for the treatment of ocular hypertension
Read More
DiaKine and Kinexum to jointly develop new combination therapy for type 1 diabetes
Read More
Recent Leland Stanford patent discloses new therapeutic agents for autoimmune diseases
Read More
CSIRO and Oncaidia enter agreement to make Apomab suitable for human trials in cancer
Read More
Regulus obtains rights from Stanford for microRNA to regulate immune responses
Read More
Mycamine approved by EMEA for Candida infections
Read More
CD8+ T-cell responses seen with cancer vaccine with GM-CSF DNA as adjuvant
Read More
APC-8024 induces immune responses in patients with HER-2/neu expressing cancers
Read More
Obovatol effects on vascular smooth muscle cells studied in rats with carotid artery injury
Read More
Astellas receives FDA approvable letter for FK-506 modified release formulation
Read More
Menarini submits regulatory filing for Factive in Europe
Read More
Taflotan approved in Denmark for glaucoma and ocular hypertension
Read More
Poniard completes enrollment in phase II clinical trial of picoplatin in colorectal cancer
Read More
LifeCycle reports positive data from phase II program for LCP-AtorFen in mixed dyslipidemia
Read More
Pluristem's preclinical study synopsis of PLX-PAD receives U.S. and German approval
Read More
New treatment options for thrombotic disorders described in recent patents
Read More
Bayer and Regeneron dose first patient in second phase III VEGF Trap-Eye study
Read More
Genzyme reports preliminary results for novel oral candidate for Gaucher's disease
Read More
Trubion and Wyeth initiate phase IIb TRU-015 study in rheumatoid arthritis
Read More
Nymox announces that 3 year follow-up study of NX-1207 for BPH is near completion
Read More
Virobay reports novel agents for rheumatoid arthritis in a recent patent
Read More